Clinical trial
A Double-Blind Controlled Pilot Study of High-Dose Capsaicin Patches in the Treatment of Pain Associated With Postherpetic Neuralgia
NCT00034710 is registered in ClinicalTrials.gov with NeurogesX as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind Controlled Pilot Study of High-Dose Capsaicin Patches in the Treatment of Pain Associated With Postherpetic Neuralgia
- Lead sponsor
- NeurogesX
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2002
- Completion date
- October 31, 2002
- Enrollment
- 42
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.